New Delhi, January 10 (IANS). India is set to become the largest healthcare private equity (PE) market by volume in the Asia Pacific region in 2024. The country had 26 percent share in the total deal volume of this sector. This information was given in a report on Friday.
According to a Bain & Company report, India is emerging as an attractive option for China for dealmaking, as its middle class is driving demand for healthcare.
Investors have focused their attention on India. Successful PE exits with strong returns such as Advent International’s sale of Mankind Pharma to BSV Group for $1.6 billion have also validated India’s buyout market, making it more attractive for future investments.
India’s strong growth is expected to continue, with healthcare spending projected to reach $320 billion by 2028.
“Over the last two years, there has been significant interest in the provider space, with funds particularly interested in building the platform, given the track record of exits in this space,” said Dhruv Sukhrani, partner and leader of India Healthcare practice at Bain & Company. Has shown strong desire to move forward.
Significant opportunities for consolidation continue. Many funds are increasing their exposure to healthcare.
Additionally, India has consistently delivered favorable returns and has enabled several successful exits for PE firms through IPOs, strategic acquisitions and sponsor-to-sponsor deals.
The report said that with a proven track record, favorable macroeconomic conditions and diverse healthcare landscape, India will continue to be a major investment destination for PE firms.
–IANS
SKT/CBT
